Mon - Fri: 08:00 - 18.00 Sat - Sun: Closed
+44 (0)1625 238630 Call today

Related Posts

Author: matrix-healthcare_admin

Matrix Healthcare Solutions (MHS) has further complimented its expansive licensed capabilities with the addition of a Manufacturers Import Authorisation (MIA) for Investigational Medicinal Products (IMP). The stringent controls and high standards required for IMP management in clinical trials have a direct impact on product registration with regulatory and competent authorities around the world. The MIA (IMP) allows Matrix Healthcare Solutions to better serve its increasing global base of customers.

Matrix Healthcare Solutions is delighted to announce we have been granted direct access to medicines from Pfizer limited, for the purposes of supplying third party clinical trials, this covers access to the full UK / EU licenced portfolio of 453 lines. The Pfizer portfolio includes a number of oncology, antibacterial, and biologic medicines.